Glaukos Announces Global Licensing Agreement With Intratus, Inc.
Novel, Non-Invasive Drug Delivery Platform Expands Glaukos’ Portfolio of Sustained Pharmaceutical Systems Includes Lead Candidate for Treatment of Dry Eye…
Pharmaceuticals, Biotechnology and Life Sciences
Novel, Non-Invasive Drug Delivery Platform Expands Glaukos’ Portfolio of Sustained Pharmaceutical Systems Includes Lead Candidate for Treatment of Dry Eye…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo…
WALLINGFORD, England–(BUSINESS WIRE)–Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium (RTOC).…
Annual Sales Tracking to Exceed Previous Year Sales of $2 million SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the…
Milciclib was well tolerated and no drug related deaths were reported 28 out of 31 treated patients were evaluable, with…
Vedolizumab subcutaneous is currently under review for approval for ulcerative colitis with the European Medicines Agency (EMA) and U.S. Food…
Blood supplies are essential for saving lives, but China’s demand for blood exceeds supply. Detraxi, a biotechnology company, is working…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces the closure of the…
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco…
SADDLEBROOK, N.J.–(BUSINESS WIRE)–Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a…